WESTBROOK, Maine, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced a major expansion of its FOCUSfactor® functional beverage portfolio across Canada, building on the successful launch of FOCUSfactor’s supplement SKUs at Walmart Canada and through McKesson Canada during Q4 2025, with sell-through and consumer feedback supporting category expansion. Beginning in April 2026, Walmart Canada will intro ...

Core Viewpoint - New to The Street is a long-running business television platform that showcases emerging growth companies and market innovators, providing them with a credible platform to articulate their business models and market opportunities [2][3][6]. Group 1: Show Details - The upcoming broadcast, Show No. 712, will air tonight at 6:30 PM EST on Bloomberg Television as sponsored programming [2][7]. - Featured companies in this episode include NEONC Technologies, SAGTEC GLOBAL, FLOKI, and ZENITH Prep Academy, each providing insights into their respective industries [2][9]. Group 2: Company Overview - New to The Street has been operational for 17 years, delivering a differentiated media model that allows companies to communicate their strategies and innovations effectively [3][6]. - The platform is recognized for its long-form interviews that focus on business models, innovation, and milestones, avoiding speculation [10]. Group 3: Digital Presence - Beyond television, New to The Street has a significant digital footprint, ranking second in reach within the financial media category on YouTube, only behind The Wall Street Journal [8]. - The platform's flagship channel reaches millions of subscribers globally, extending the impact of each broadcast beyond its initial airing [8].

Role Supports Synergy’s Expanding Presence in Mexico, Including Initial Product Shipments to Costco MexicoWESTBROOK, Maine, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced that Pedro Colmenares has been appointed Director of Sales & Marketing for Mexico & Latin America. In this role, Mr. Colmenares will lead commercial strategy, market expansion, and go-to-market execution across the region. Mr. ...

Core Insights - Synergy CHC Corp. has announced new Direct Store Delivery (DSD) partnerships with Pine State Beverage, Fuhrer Beverage Company, and Banko Beverage Co. to enhance the distribution of its FOCUSfactor products in Maine and Pennsylvania [1][2][3] Group 1: Partnerships and Distribution - The new partnerships are part of Synergy's strategy to build a comprehensive nationwide DSD network, strengthening its distribution coverage and supporting the early success of the FOCUSfactor RTD portfolio [2][7] - Pine State Beverage, founded in 1941, will distribute the entire FOCUSfactor RTD portfolio across Maine, leveraging its strong relationships in various retail channels [4] - Fuhrer Beverage Company, established in 1982, will handle the distribution of FOCUSfactor products throughout Pennsylvania, recognized for its extensive network and high service standards [5] - Banko Beverage Co., a family-owned distributor since 1933, will also distribute the full FOCUSfactor lineup in Pennsylvania, known for its commitment to quality and service [6] Group 2: Growth and Market Expansion - These agreements mark a significant advancement in Synergy's disciplined plan to establish a national DSD network, enhancing its retail footprint and accelerating growth for the FOCUSfactor functional beverage platform [7] - The company anticipates announcing additional distribution partners and market expansions in the near future, following strong early performance in all launch regions [7][8]

Core Insights - Synergy CHC Corp. has expanded its retail distribution of FOCUSfactor Ready-to-Drink functional beverages by adding five new Direct Store Delivery partners across five states [1][2][10] - The company has achieved DSD coverage in ten out of 50 U.S. states within the first six weeks of launch, indicating a rapid national expansion strategy [2][10] Distribution Partnerships - The new partnerships include three distributors from The Sheehan Family Companies, enhancing FOCUSfactor's reach in New York, Wisconsin, and Virginia [4] - Craft Beer Guild will distribute the full FOCUSfactor RTD portfolio throughout New York, leveraging its consultative sales and strategic marketing expertise [5] - Beechwood Distributors will handle distribution in Wisconsin, utilizing its strong retail relationships [6] - Specialty Beverage will distribute the complete FOCUSfactor RTD line in Virginia, known for its exceptional service [7] - Bill's Distributing will cover Alaska, focusing on building premium brands in the local market [8] - Mid-State Beverage Co. will distribute FOCUSfactor products in Pennsylvania, recognized for its consistency and community involvement [9] Strategic Goals - The addition of these five new agreements marks a significant advancement in Synergy's plan to establish a comprehensive 50-state DSD network [10] - The company anticipates announcing further partnerships and market expansions in the near future, driven by strong early performance in all launch regions [10] Company Overview - Synergy CHC Corp. develops and markets consumer health and wellness products, with FOCUSfactor being a clinically studied brain health supplement and functional beverage line [11] - FOCUSfactor has a 25-year legacy and established distribution in the U.S., Canada, and the U.K. through major retailers [11] - The brand is experiencing growth and penetrating new markets, with recent retail wins expected to drive significant gains in late 2025 [11]

Financial Data and Key Metrics Changes - For Q3 2025, net revenue was $8 million, an increase of 12.4% from $7.1 million in the same quarter last year [11] - Gross margin improved to 70.9% from 67.2% year-over-year, driven by a favorable product mix [11] - Operating expenses rose to $4.4 million from $3.7 million, attributed to costs associated with being a public company and launching the beverage division [11] - Income from operations increased by 21.8% to $1.28 million compared to $1.05 million in Q3 2024 [11] - Net income decreased to $125,300 from $783,600 in the prior year [11] - Earnings per share fell to $0.01 from $0.11, while adjusted EBITDA per share decreased to $0.15 from $0.18 [12] Business Line Data and Key Metrics Changes - Beverage revenue for Q3 was $159,000, indicating early-stage growth in this segment [16] - The supplement business saw a price increase of 11% for Costco, with gross margins around 75% [17] Market Data and Key Metrics Changes - The company secured major distribution agreements, including with EG America and Wakefern Food Group, expanding its retail presence significantly [6][9] - New partnerships with AlaBev and Atlantic Importing Company will enhance distribution in the Southeast and New England regions [6] Company Strategy and Development Direction - The company is focused on expanding its beverage and supplement categories, leveraging new leadership and distribution partnerships [5][10] - A public offering raised $4.4 million to support retail rollouts and inventory build-up, enhancing operational flexibility [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's positioning for growth through 2025 and into 2026, citing strong execution and new retail authorizations [10][24] - The company is actively expanding its direct-to-store distribution network to capitalize on market opportunities [20] Other Important Information - The company has over 3 million cans of drink inventory available, with ongoing production to meet demand [24] - Management highlighted the importance of adding key employees to build out the sales network [24] Q&A Session Summary Question: Contribution from beverages in the quarter - Beverage revenue for Q3 was $159,000 [16] Question: Dynamics of product mix and highest margin revenue source - The supplement business saw an 11% price increase, with gross margins around 75% [17] Question: Expectations for G&A expenses moving forward - G&A expenses may increase due to new executive additions and expansion of the DSD distribution network [19]

Financial Performance - For the three months ended September 30, 2025, the company reported revenue of $8,010,112, an increase from $7,126,333 for the same period in 2024, representing a growth of approximately 12.4%[164]. - Gross profit for the three months ended September 30, 2025, was $5,680,816, or 71% of revenue, compared to $4,790,432, or 67% of revenue in 2024, marking an increase of $890,384, or 19%[168]. - Net income for the three months ended September 30, 2025, was $125,327, a decrease from $783,593 in 2024, attributed to higher expenses and other income in 2024[173]. - For the nine months ended September 30, 2025, total revenue was $24,315,642, a decrease from $24,563,039 in 2024, with Nutraceuticals revenue declining due to a new product sell-in that did not repeat[175]. - EBITDA for the three months ended September 30, 2025, was $1,311,570, compared to $1,329,334 in 2024, reflecting a slight decrease[162]. - For the nine months ended September 30, 2025, net income was $2,474,827, an increase from $2,019,309 in 2024, primarily due to a gain on loan settlements[182]. Expenses and Cash Flow - Operating expenses for the three months ended September 30, 2025, included selling and marketing expenses of $2,729,767, up from $2,509,440 in 2024, indicating an immaterial increase[169]. - The cost of revenue for the three months ended September 30, 2025, was $2,329,296, slightly down from $2,335,901 in 2024, due to a favorable product mix[167]. - Interest expense for the three months ended September 30, 2025, was $1,164,402, an increase from $705,088 in 2024, primarily due to new loan advances[172]. - For the nine months ended September 30, 2025, net cash used in operating activities was $3,209,149, compared to $1,377,479 for the same period in 2024, indicating a significant increase in cash outflow[185][186]. - Net cash provided by financing activities for the nine months ended September 30, 2025, was $3,515,856, a substantial increase from $895,972 in 2024, primarily due to new loans[187]. - Proceeds from issuing common stock amounted to $3,880,462 for the nine months ended September 30, 2025, while there were no proceeds from common stock issuance in 2024[188]. Strategic Plans and Market Position - The company plans to grow its current product lines and expand into new markets, specifically focusing on increased distribution for the recently launched ready-to-drink beverage under the FOCUSfactor brand[189]. - The company intends to pursue additional strategic acquisitions to enhance its brand portfolio and is actively evaluating potential opportunities[189]. Other Financial Information - As of September 30, 2025, the company had cash on hand of $1,006,489 and restricted cash of $100,000 held for credit card collateral[183]. - There were no off-balance sheet arrangements during the nine months ended September 30, 2025, or the year ended December 31, 2024[190]. - The effect of inflation on operating results was not significant for the nine months ended September 30, 2025, or 2024[191]. - Critical accounting estimates include those related to revenue recognition and accounts receivable allowances, which are significant for understanding the company's financial results[192].

Financial Performance - Revenue for Q3 2025 was $8.0 million, a 12.4% increase from $7.1 million in Q3 2024[6] - Income from operations rose to $1.28 million, a 21.8% increase compared to $1.05 million in Q3 2024[7] - Adjusted EBITDA for Q3 2025 was $1.52 million, a 13.4% increase from $1.34 million in Q3 2024[9] - Total revenue for Q3 2025 was $8,010,112, a 12.4% increase from $7,126,333 in Q3 2024[22] - Gross profit for the nine months ended September 30, 2025, was $18,083,441, compared to $17,141,106 for the same period in 2024, reflecting a 5.5% increase[22] - Net income after tax for the nine months ended September 30, 2025, was $2,474,827, up from $2,019,309 in 2024, representing a 22.6% increase[22] - Comprehensive income for the nine months ended September 30, 2025, was $2,486,689, compared to $2,127,657 in 2024, reflecting a 16.9% increase[22] Profitability Metrics - Gross margin improved to 70.9% in Q3 2025, up from 67.2% in Q3 2024, driven by a favorable product mix[6] - Net income decreased to $125.3 thousand in Q3 2025, down from $783.6 thousand in Q3 2024[8] - Operating expenses for Q3 2025 totaled $4,400,806, an increase of 17.7% from $3,739,557 in Q3 2024[22] - Interest expense for the nine months ended September 30, 2025, was $4,352,840, compared to $2,559,454 in 2024, indicating a 70.0% increase[22] Cash and Liabilities - As of September 30, 2025, cash and cash equivalents increased to approximately $1.0 million from $687.9 thousand at the end of 2024[10] - Cash and restricted cash at the end of the period was $1,106,489, compared to $359,375 at the end of the same period in 2024[24] - Net cash used in operating activities for the nine months ended September 30, 2025, was $(3,209,149), compared to $(1,377,479) in 2024[24] - The company reduced outstanding liabilities by $3.3 million during the third quarter[5] - Proceeds from issuing common stock amounted to $3,880,462 during the nine months ended September 30, 2025[24] Strategic Initiatives - Synergy completed a $4.4 million public offering in August 2025, enhancing working capital for growth initiatives[2] - Synergy appointed former Costco executive Teresa Thompson to the Board of Directors to strengthen retail expertise[5] - FOCUSfactor was named the 1 Pharmacist Recommended OTC Memory Supplement for 2025-2026, highlighting brand leadership[5] Other Financial Adjustments - The company reported a foreign currency translation adjustment loss of $(26,077) for Q3 2025[22]

Core Insights - Synergy CHC Corp. reported its financial results for Q3 2025, marking its 11th consecutive quarter of profitability and achieving double-digit revenue growth alongside significant gross margin expansion [2][5]. Financial Performance - Revenue for Q3 2025 was $8.0 million, representing a 12.4% increase from $7.1 million in Q3 2024 [5][8]. - Gross margin improved to 70.9% in Q3 2025, up from 67.2% in Q3 2024, primarily due to a favorable product mix [5][8]. - Operating expenses rose to $4.4 million, a 17.7% increase compared to $3.7 million in Q3 2024, driven by costs associated with being a public company and launching the beverage division [6][8]. - Income from operations increased to $1.28 million, up 21.8% from $1.05 million in Q3 2024, attributed to improved gross margins [6][8]. - Net income for Q3 2025 was $125.3 thousand, down from $783.6 thousand in Q3 2024, with earnings per share at $0.01 compared to $0.11 in the prior year [7][8]. Business Developments - The company expanded its retail authorizations and distribution partnerships, notably with Kroger and Wakefern, enhancing its market reach across North America [2][8]. - A public offering completed in August 2025 raised $4.4 million, providing additional working capital for growth and brand expansion [2][8]. - Synergy appointed Teresa Thompson, a former Costco executive, to its Board of Directors, enhancing its expertise in retail and consumer health [8]. - FOCUSfactor was recognized as the 1 Pharmacist Recommended OTC Memory Supplement for 2025-2026 by Pharmacy Times, highlighting its market leadership [8]. Balance Sheet and Cash Flow - As of September 30, 2025, the company had approximately $1.0 million in cash and cash equivalents, up from $687.9 thousand at the end of 2024 [10][20]. - Working capital surplus increased to $16.68 million from a deficit of $1.12 million at the end of 2024 [10][20]. - Inventory stood at $2.1 million, compared to $1.7 million at the end of 2024 [10][20]. - Cash used in operating activities for the nine months ended September 30, 2025, was $3.21 million, compared to $1.38 million for the same period in 2024 [11][25].

Core Insights - Synergy CHC Corp. has announced a strategic distribution partnership with C&M Sales to enhance the availability of its FOCUSfactor® Focus + Energy products in Arkansas, capitalizing on the growing functional beverage market [1][4]. Company Overview - Synergy CHC Corp. specializes in consumer health and wellness products, with flagship brands including FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line with a 25-year legacy, distributed in the U.S., Canada, and the U.K. through major retailers [5]. - Flat Tummy focuses on women's wellness and weight management, complementing Synergy's product portfolio [5]. Partnership Details - C&M Sales, a well-established beverage distributor in Arkansas with nearly 90 years of experience, will serve as Synergy's new Direct Store Delivery partner. The company has a strong reputation for brand-building and services over 3,500 accounts statewide [2][3]. - The partnership aims to leverage C&M Sales' long-standing relationships and expertise to expand FOCUSfactor's market presence in the functional beverage category [4]. Market Position - The non-alcohol division of C&M Sales, established in 2019, has quickly become a preferred distributor for non-alcoholic beverages in Arkansas, representing over 20 leading brands [3][6]. - The collaboration is expected to enhance the visibility and availability of FOCUSfactor products, driving innovation and consumer demand in the functional beverage sector [4].